Research Article

Key stakeholders’ perspectives on providing oral pre-exposure prophylaxis as HIV-prevention standard of care in clinical trials in South Africa

Published in: African Journal of AIDS Research
Volume 22 , issue 1 : Entrepreneurship and Africa’s Cultural Context , 2024 , pages: 18–26
DOI: 10.2989/16085906.2023.2169177
Author(s): Ivana Beesham University of the Witwatersrand, South Africa, Cecilia Milford University of the Witwatersrand, South Africa, Dvora L Joseph Davey University of Cape Town, South Africa, Jenni Smit University of the Witwatersrand, South Africa, Leila E Mansoor University of KwaZulu-Natal, South Africa, Mags Beksinska University of the Witwatersrand, South Africa,
Keywords: HIV prevention options, PrEP, post-trial access, standard of prevention,
Download full text Get new issue alerts

Abstract

Introduction: HIV-prevention and endpoint-driven clinical trials enrol individuals at substantial risk of HIV. Recently, these trials have provided oral pre-exposure prophylaxis (PrEP) as HIV-prevention standard of care; however, data on PrEP uptake and use during the trial and post-trial access are lacking.
« Evaluating HIV policy: a gender analysis of the representation of women and men in UNAIDS HIV-prevention guidelines
Roles and responsibilities of expert clients in adolescent HIV service delivery in Eswatini: a conventional content analysis »

Get new issue alerts for African Journal of AIDS Research

CAPTCHA Reload CAPTCHA